Renal fibrosis in cyclosporin A-treated renal allograft recipients: Morphological findings in relation to renal hemodynamics

Transplant International

Volumn 9, Issue 5, 1996, Pages 492-498

  Jacobson, Stefan H ^a   Jaremko, Georg ^a   Duraj, Frans F ^a   Wilczek, Henryk E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fibrosis, kidney transplantation, cyclosporin A; Kidney transplantation, fibrosis, cyclosporin A

Indexed keywords

CHLORIDE ION; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PHOSPHATE; POTASSIUM ION; SODIUM ION;

ADULT; AGED; ARTICLE; CHLORIDE URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DIURESIS; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY PLASMA FLOW; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; MORPHOLOGY; PHOSPHATE URINE LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SODIUM URINE LEVEL;

EID: 0029742003     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1996.tb00994.x     Document Type: Article

References (38)

1. Barros EJG, Boim MA, Ajzen H, Ramos OL, Schor N (1987) Glomerular hemodynamics and hormonal participation on cyclosporin nephrotoxicity. Kidney Int 32: 19-25
2. Bennet WM, Houghton DC, Buss WC (1991) Cyclosporine-induced renal dysfunction. Correlations between cellular events and whole kidney function. J Am Soc Nephrol 1: 1212-1219
3. Berg KJ, Forre O, Bjerkhoel F (1986) Side effects of cyclosporine A treatment in patients with rheumatoid arthritis. Kidney Int 29: 1180-1187
4. Bergstrand A, Bohman SO, Farnsworth A, Gokel HM, Krause PH, Lang W, Mihatsch MJ, Oppedal B, Sell S, Sibley RK, Thiru S, Verani R, Wallace AC, Zollinger HU, Ryffel B, Thiel G, Wonigeit K (1985) Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporine A: results of an international workshop. Clin Nephrol 24: 107-119
5. Calne RY, White DG, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K (1978) Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet II: 1323-1327
6. Curtis JJ, Luke RG, Dubovsky E, Diethelm AG, Whelchel JD, Jones P (1986) Cyclosporine in therapeutic doses increases renal allograft vascular resistance. Lancet II: 477-479
7. D'Ardenne AJ, Dunhill MS, Thompson JF, McWhinnic D, Wood RFM, Morris PJ (1986) Cyclosporine and renal graft histology. J Clin Pathol 39: 145-151
8. Dieperink H, Kemp E, Leyssac PP, Starklint H (1986) Cyclosporine A: effectiveness and toxicity in a rat model. Clin Nephrol 25: S46-50
9. Dieperink H, Leyssac PP, Starklint H, Kemp E (1988) Long-term cyclosporine A nephrotoxicity in the rat. Effects on renal function and morphology. Nephrol Dial Transplant 3: 317-326
10. Donatsch P, Absich E, Hornberger M, Traber R, Trapp M, Voges R (1981) A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2: 19-32
11. Dunnill MS, Halley W (1973) Some observations on the quantitative anatomy of the kidney. J Pathol 110: 113-121
12. English J, Evans A, Houghton DC, Bennet WM (1987) Cyclosporine-induced acute renal dysfunction in the rat. Transplantation 44: 135-141
13. Farnsworth A, Hall BM, Ng ABP. Duggin GG, Horvath JS, Sheil AG, Tiller DJ (1984) Renal biopsy morphology in renal transplantation. Am J Surg Pathol 8: 243-252
14. Ferguson RM, Rynasicwicz JJ, Sutherland DER, Simmons RL, Najarian JS (1982) Cyclosporine A in renal transplantation: a prospective randomized trial. Surgery 92: 175-182
15. Humes HD, Jackson NM, O'Connor RP, Hunt DA, White MD (1985) Pathogenetic mechanisms of nephrotoxicity: insights into cyclosporine nephrotoxicity. Transplant Proc 17: 51-62
16. Jacobson SH, Eklöf O, Eriksson CG, Lins LE, Tidgren B, Winberg J (1989) Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow-up. BMJ 299: 703-706
17. Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Nephrotoxicity of cyclosporine A in liver and kidney transplantation. Lancet 1: 470-471
18. Klintmalm G, Bohman SO, Sundelin B, Wilczek H (1984) Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporine treatment: beneficial effect of low doses in early post-transplant period. Lancet II: 950-954
19. Kopp JB, Klotman PE (1990) Cellular and molecular mechanisms of cyclosporine nephrotoxicity. J Am Soc Nephrol 1: 162-179
20. Lundgren G, Albrechtsen D, Brynger H, Flatmark A, Frödin L, Gäbel H, Persson H, Groth CG (1987) Improved early course after cadaveric renal transplantation by reducing the cyclosporin dose and adding azathioprine. Transplant Proc 19: 2074-2079
21. Mihatsch MJ, Thiel G, Spichtin HP, Oberholzer M, Brunner FP, Harder F, Olivieri V, Bremer R, Ryffel B, Stöcklin E, Torhorst J, Gudat F, Zollinger HU, Loertscher R (1983) Morphological findings in kidney transplants after treatment with cyclosporine. Transplant Proc 15: 2821-2835
22. Mihatsch MJ, Thiel G, Ryffel B (1988) Histopathology of cyctosporine nephrotoxicity. Transplant Proc 20: 759-771
23. Morris PJ, Chapman JR, Allen RD, Ting A, Thompson JF, Dunnill MS, Wood RF (1987) Cyclosporine conversion versus conventional immunosuppression: long-term follow-up and histological evaluation. Lancet II: 586-591
24. Murray BM, Paller MS, Ferris TE (1985) Effect of cyclosporine administration on renal haemodynamics in conscious rats. Kidney Int 28: 767-774
25. Myers BD (1986) Cyclosporine nephrotoxicity. Kidney Int 30: 964-974
26. Nizze H, Mihatsch MJ, Zollinger HU, Brocheriou C, Gokel JM, Henry K, Sloane JP, Stovin PG (1988) Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants. Clin Nephrol 30: 248-260
27. Palestine AG, Nussenblatt RB, Chan CC (1984) Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 77: 652-656
28. Palestine AG, Austin HA, Nussenblatt RB (1986) Renal tubular function in cyclosporine-treated patients. Am J Med 81: 419-424
29. Savoldi S, Scolan F, Sandrini S, Scaini P, Sacchi G, Tardanico R, Camerini C, Salerni B, Tonini G, de Nobili U (1988) Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation. Transplant Proc 20: 777-784
30. Sullivan BA, Hak LJ, Finn WF (1985) Cyclosporine nephrotoxicity: studies in laboratory animals. Transplant Proc 17: 145-149
31. Thiru S, Maher ER, Hamilton DV, Evans DB, Calne RY (1983) Tubular changes in renal transplant recipients on cyclosporine. Transplant Proc 15: 2846-2851
32. Versluis DJ, Wenting GJ, Derkx FH, Schalekamp MA, Jeekel J, Weimar W (1987) Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation and why. Transplantation 44: 387-389
33. Versluis DJ, Wenting GJ, Jeekel J, Weimar W (1988) The influence of cyclosporine A on proximal tubular function in renal allografts. Transplant Proc 20: 686-690
34. Wallace AC (1985) Histopathology of cyclosporine. Transplant Proc 16: 117-122
35. Weibel ER (1979) Stereological methods I. Practical methods for biological morphometry. Academic Press, London, pp 101-161
36. Wilczek HE (1990) Percutaneous needle biopsy of the renal allograft. A clinical safety evaluation of 1129 biopsies. Transplantation 50: 790-797
37. Wilczek H, Bohman SO, Klintmalm G, Groth CG (1988) Five year serial renal graft biopsy study in cyclosporine-treated patients. Transplant Proc 20: 812-815
38. Zollinger HU, Mihatsch MJ (1978) Renal pathology in biopsy. Light, electron and immunofluorescent microscopy and clinical aspects. Springer Verlag, Berlin